Internal Medicine, Pulmonary Disease · Beckley, WV
NPI
1518917632
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
421 Carriage Dr
Beckley, WV, 25801
Phone (304) 256-0242
Groups this clinician bills Medicare through
Medicare paid, 2024
$216K
4,292 services
Medicare patients, 2024
602
Average age 72
Drug cost, 2024
$3.2M
2,905 prescriptions
Company payments, 2025
$2,262
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria R Boustani was code 99214 (office e&m - established), 749 times for 350 patients. In total Maria R Boustani billed 4,292 services in 48 codes, and Medicare paid $216K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-11-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 749 | 350 | $89.24 | $67K |
| 71046 X-ray - Chest | Office | 494 | 368 | $15.32 | $7,567 |
| 99213 Office E&M - Established | Office | 457 | 297 | $64.83 | $30K |
| 99232 Hospital E&M - Subsequent | Facility | 362 | 97 | $63.47 | $23K |
| 94060 Pulmonary Function Testing | Office | 314 | 296 | $26.72 | $8,391 |
| 94726 Pulmonary Function Testing | Office | 314 | 296 | $38.76 | $12K |
| 94729 Pulmonary Function Testing | Office | 311 | 293 | $39.20 | $12K |
| 99223 Hospital E&M - Initial | Facility | 128 | 107 | $134.26 | $17K |
| 99233 Hospital E&M - Subsequent | Facility | 89 | 32 | $96.35 | $8,575 |
| 99203 Office E&M - New | Office | 88 | 88 | $74.12 | $6,522 |
| 95810 Sleep Study | Office | 42 | 42 | $89.68 | $3,767 |
| 95811 Sleep Study | Office | 38 | 37 | $96.43 | $3,664 |
| 94060 Pulmonary Function Testing | Facility | 28 | 28 | $7.39 | $207 |
| 94729 Pulmonary Function Testing | Facility | 28 | 28 | $6.92 | $194 |
| 94726 Pulmonary Function Testing | Facility | 28 | 28 | $8.88 | $249 |
By year: 2022 $161K for 2,942 services; 2023 $207K for 3,874 services; 2024 $216K for 4,292 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maria R Boustani prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 463 prescriptions and refills. In total Maria R Boustani wrote 2,905 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 463 | 611 | 166 | $17K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 430 | 598 | 112 | $376K |
| Breo Ellipta Fluticasone/Vilanterol | 181 | 229 | 57 | $88K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 127 | 155 | 30 | $72K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 109 | 135 | 32 | $83K |
| Glassia Alpha-1-Proteinase Inhibitor | 107 | 107 | 12 | $1.3M |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 99 | 153 | 41 | $14K |
| Montelukast Sodium Generic | 98 | 214 | 23 | $817 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 75 | 77 | 19 | $36K |
| Incruse Ellipta Umeclidinium Bromide | 58 | 75 | 17 | $25K |
| Ventolin Hfa Albuterol Sulfate | 49 | 63 | 21 | $3,870 |
| Symbicort Budesonide/Formoterol Fumarate | 49 | 63 | 17 | $14K |
| Spiriva Handihaler Tiotropium Bromide | 47 | 63 | 11 | $30K |
| Spiriva Respimat Tiotropium Bromide | 45 | 47 | 13 | $24K |
| Levothyroxine Sodium Generic | 39 | 98 | Under 11 | $460 |
Brand drugs: 1,909 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maria R Boustani $2,262 ($2,262 in general payments such as food, travel and fees) from 15 companies. The largest payer was GlaxoSmithKline, LLC. with $1,399.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 11 | $1,399 |
| Genzyme Corporation SNY | 15 | $270 |
| UCB, Inc. UCB.BR | 24 | $196 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $157 |
| Regeneron Pharmaceuticals, Inc. REGN | 1 | $57.8 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $36.14 |
| Verona Pharma, Inc. VRNA | 1 | $31.76 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $24.17 |
| Baxter Healthcare BAX | 1 | $21.69 |
| Actelion Pharmaceuticals US, Inc. JNJ | 1 | $18.87 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.